D. E. Shaw & Co., Inc.

SEC CIK: 0001009207
Latest filing: Aug 14, 2026

SEC filings (opens in a new tab)

SEEL holding history

Seelos Therapeutics, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SEEL overview All 13F holders of SEEL Full Q2 2026 holdings

Shares (Q4 2021): 0; Sold out in Q4 2021
Value: $0
% of portfolio: 0.0%
Quarters held: 2; Since Q2 2021

Holdings of SEEL by D. E. Shaw & Co., Inc., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q4 2021	0	$0	0.0%	−114,729−100.0%	Sold out	Holders
Q3 2021	114,729	$276.0K	<0.1%	+21,170+22.6%	Added	Holders
Q2 2021	93,559	$247.0K	<0.1%	+93,559	New	Holders